Free Trial
NYSEARCA:IHE

iShares U.S. Pharmaceuticals ETF (IHE) Price, Holdings, & News

iShares U.S. Pharmaceuticals ETF logo
$66.16 +1.29 (+1.99%)
As of 03:53 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

About iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE)

Key Stats

Today's Range
$64.72
$66.19
50-Day Range
$61.00
$72.85
52-Week Range
$58.97
$73.28
Volume
58,065 shs
Average Volume
65,797 shs
Market Capitalization
$601.33 million
Assets Under Management
$555.12 million
Dividend Yield
1.76%
Net Expense Ratio
0.40%
Aggregate Rating
Moderate Buy

ETF Overview

iShares U.S. Pharmaceuticals ETF, formerly iShares Dow Jones U.S. Pharmaceuticals Index Fund (the Fund), is an exchange traded fund. The Fund seeks investment results that correspond generally to the price and yield performance of the Dow Jones U.S. Select Pharmaceuticals Index (the Index). The Index measures the performance of the pharmaceuticals sector of the United States equity market, and includes pharmaceutical companies such as manufacturers of prescription or over-the-counter drugs or vaccines, but excludes producers of vitamins. The Fund invests in a representative sample of securities included in the Index that collectively has an investment profile similar to the Index. Due to the use of representative sampling, the Fund may or may not hold all of the securities that are included in the Index. The Fund's investment advisor is BlackRock Fund Advisors.

iShares U.S. Pharmaceuticals ETF Expenses

TypeIHEHealth Care ETFsEquity ETFsNYSEARCA ETFsAll ETFs
Management Fee0.40%0.57%0.56%0.51%0.53%
Other Expenses0.00%0.30%0.48%0.56%0.52%
Total Expense0.40%0.70%0.72%0.73%0.71%
Fee Waiver0.00%-0.45%-0.49%-0.66%-0.54%
Net Expense0.40%0.61%0.63%0.58%0.60%
Receive IHE Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for iShares U.S. Pharmaceuticals ETF and its competitors with MarketBeat's FREE daily newsletter.

IHE ETF News Headlines

IHE Contraction Is Not Justified By Fundamental Data
The Crypto Market is About to Change Lives
I've discovered something so significant about the 2025 crypto market that I had to put everything else aside and write a book about it. This isn't just another Bitcoin prediction – it's a complete roadmap for what I believe will be the biggest wealth-building opportunity of this decade. The evidence is so compelling, I'm doing something that probably seems insane: I'm giving away my entire book for free.
Healthcare ETFs tumble as UnitedHealth stock weighs
See More Headlines

IHE ETF - Frequently Asked Questions

iShares U.S. Pharmaceuticals ETF's stock was trading at $65.72 on January 1st, 2025. Since then, IHE stock has increased by 0.1% and is now trading at $65.7540.
View the best growth stocks for 2025 here
.

iShares U.S. Pharmaceuticals ETF shares split on the morning of Thursday, March 7th 2024. The 3-1 split was announced on Thursday, March 7th 2024. The newly created shares were distributed to shareholders after the market closes on Thursday, March 7th 2024. An investor that had 100 shares of stock prior to the split would have 300 shares after the split.

Top institutional investors of iShares U.S. Pharmaceuticals ETF include Massachusetts Wealth Management (0.17%), Institute for Wealth Management LLC. (0.12%), Janney Montgomery Scott LLC (0.08%) and Arkansas Financial Group Inc. (0.07%).

Shares of IHE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that iShares U.S. Pharmaceuticals ETF investors own include Meta Platforms (META), NVIDIA (NVDA), Broadcom (AVGO), Visa (V), Adobe (ADBE), Lam Research (LRCX) and Advanced Micro Devices (AMD).

Fund Details

Issuer
iShares
Fund Name
iShares U.S. Pharmaceuticals ETF
Tax Classification
Regulated Investment Company
Stock Exchange
NYSEARCA
Current Symbol
NYSEARCA:IHE
Inception Date
5/1/2006
Fund Manager
Diane Hsiung, Jennifer Hsui, Greg Savage, Alan Mason
Phone
N/A

Fund Focus

Asset Class
Equity
Benchmark
Dow Jones U.S. Select Pharmaceuticals Index
Category
Sector
Focus
Health Care
Development Level
Developed Markets
Region
North America
Number of Holdings
41

Fund Statistics

Assets Under Management
$555.12 million
Average Daily Volume
$153,576.30
Discount/Premium
-0.06%

Administrator, Advisor and Custodian

Administrator
Citibank, N.A.
Advisor
BlackRock Fund Advisors
Custodian
Citibank, N.A.
Distributor
BlackRock Investments, LLC
Transfer Agent
Citibank, N.A.
Trustee
N/A
Lead Market Maker
Latour Trading

Options

Optionable
Optionable
Options Volume
2
Put Options
2
Call Options
2
Short Interest
229,200 shs

Miscellaneous

Beta
0.63
Creation Unit
50,000
Creation Fee
$306.00
Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

Top 10 IHE Holdings

IHE Sector Exposure

IHE Industry Exposure


This page (NYSEARCA:IHE) was last updated on 4/24/2025 by MarketBeat.com Staff
From Our Partners